TODD MACKILLOP: Open Payments
NPI 1164511572 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 106 payments from 19 companies in 2025. Trend: 2023 $1,046 · 2024 $1,708 · 2025 $2,173
Food & beverage: $2,173
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 23 | $610 |
| ABBVIE INC. | 16 | $263 |
| Janssen Pharmaceuticals, Inc | 10 | $183 |
| Axsome Therapeutics, Inc. | 8 | $159 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Lundbeck LLC | 7 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| Neos Therapeutics, LP | 4 | $79 |
| Almatica Pharma LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
Products named: HETLIOZ, VRAYLAR, REXULTI, FANAPT, Auvelity, SPRAVATO, CAPLYTA, Adzenys XR-ODT.
Industry payments across NC — which companies pay providers there.
